By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Xenetic Biosciences  

Greener House
66-68 Haymarket
  London  SW1Y 4RF  United Kingdom
Phone: 44-0-20-3021-1500 Fax: 44-0-20-3021-1511


Company News
Xenetic Biosciences’ Polyxen Platform Technology Accepted For Poster Presentation At The 13th Annual Protein Engineering Summit (PEGS) Boston 4/10/2017 5:50:38 AM
Xenetic Biosciences Reports 2016 Year End Financial Results And Provides Business Update 4/3/2017 12:23:52 PM
Xenetic Biosciences To Ring Nasdaq Stock Market Opening Bell On March 30, 2017 3/29/2017 6:38:08 AM
Xenetic Biosciences Provides Update On Patent Portfolio Development 3/27/2017 7:33:49 AM
Xenetic Biosciences Receives $3 Million Milestone Payment From Shire (SHPG) For PSA-Recombinant SHP656 In Development For Long-Acting Treatment For Hemophilia 1/6/2017 11:06:52 AM
Xenetic Biosciences Appoints Curtis A. Lockshin, Ph.D. As Chief Scientific Officer 1/4/2017 10:02:30 AM
Xenetic Biosciences Expands Management Team With Key Appointment Of Jeffrey F. Eisenberg As Chief Operating Officer 12/5/2016 11:29:51 AM
Xenetic Biosciences To Host Quarterly Update Conference Call And Webcast 11/23/2016 8:48:50 AM
Xenetic Biosciences Appoints Edward J. Benz, Jr., M.D., Former Dana-Farber Cancer Institute CEO, To Its Board Of Directors 11/22/2016 10:38:29 AM
Xenetic Biosciences Reports Third Quarter Financial Results and Provides Business Update 11/15/2016 11:36:58 AM